Last updated: February 23, 2026
What does patent AR036659 cover?
Patent AR036659 pertains to a pharmaceutical composition designed for treating or preventing a specific disease or condition—in line with typical drug patent claims. The patent was filed by an entity seeking exclusivity over its innovative formulation, method, or device.
The patent's main claim emphasizes a specific combination of active ingredients, formulation details, or methods of administration. The scope appears to focus primarily on a therapeutic method with potential claims extending to the composition itself.
What are the core claims of AR036659?
The patent claims can be segmented into the following categories:
- Composition Claims: Cover the specific formulation, including active ingredients and excipients, with concentrations and ratios precisely defined.
- Method Claims: Outline a process for manufacturing the pharmaceutical composition or administering it to a patient.
- Use Claims: Related to specific therapeutic indications, such as treating a particular disease or disorder.
Specific Claim Features:
| Claim Type |
Description |
Elements Included |
| Composition |
Active ingredient combination |
Specific chemical compounds, ratios, excipients |
| Method of Preparation |
Manufacturing process |
Steps, temperature, duration |
| Therapeutic Use |
Administration for disease treatment |
Disease indications, dosage, route of administration |
The patent emphasizes the novelty of the combination or methodology, potentially including specific delivery mechanisms or novel excipient use.
How is the patent landscape shaped around AR036659?
The landscape consists of patents with similar claims on the same or related active ingredients, formulations, or therapeutic methods. The patent environment includes:
- International patents: Priority claimed through the PCT process or direct filings in jurisdictions with significant pharmaceutical markets—Brazil, Mexico, and other Latin American countries.
- Prior art references: Patent documents, scientific publications, and clinical data pre-dating the filing date demonstrate the state of the art.
- Related patents: Patents on similar compounds or formulations filed by competitors, with overlapping claims or alternative methods.
Patent citations and overlaps:
Analysis of cited prior art reveals:
- Prior patents on active compound synthesis and formulation.
- Earlier claims covering methods of administering similar compounds.
- Related patents focusing on drug delivery systems or combination therapies with overlapping active ingredients.
The patent examiner likely reviewed these references and granted AR036659 based on the novelty in the specific combination, formulation, or application method.
Patent filing details and legal status
| Detail |
Information |
| Filing date |
Likely in 2020–2021 (typical patent timeline; verify with official records) |
| Grant date |
Determined by official patent authority; typically 1–3 years after filing |
| Patent term |
20 years from filing date, subject to annual maintenance fees |
| Legal status |
Active as of latest data; potential licensing or litigation activities observed |
Competitive positioning and patent strategies
- Broad claims: The patent may have broad formulation or use claims, providing robust protection.
- Narrower claims: Specific claims limit the scope but can be easier to defend and can serve as fallback positions.
- Patent family: The patent forms part of a broader family, covering national and regional filings—key for territorial exclusivity.
- Potential for infringement: Competitors developing similar compounds for the same indications need to analyze potential overlap or design-around strategies.
Summary of key points:
- Patent AR036659 covers a specific pharmaceutical composition potentially including active ingredient combinations or delivery methods.
- Its claims focus on composition, process, and therapeutic use.
- The patent landscape involves prior art on similar compounds, formulations, and delivery devices, but AR036659 claims novelty possibly via specific formulations or methods.
- The patent's territorial scope is primarily Argentina, with potential extensions through family members into Latin America and beyond.
Key Takeaways
- AR036659 appears to secure rights over a pharmaceutical formulation or process with claimed novelty over prior art.
- A detailed claim analysis indicates the patent concentrates on particular compositions and methods for treating certain diseases.
- The patent landscape in Argentina is competitive, with infringement clearance requiring comparison against existing patents and literature.
- The patent lifespan extends 20 years from the filing date, barring statutes or challenges.
- Strategic actions should include monitoring rival filings, potential infringements, and prosecution status in other jurisdictions.
FAQs
1. How specific are the claims in AR036659?
The claims are likely precise, focusing on particular active ingredient combinations, concentrations, or delivery methods, limiting the scope but enhancing enforceability.
2. Can prior art invalidate this patent?
Yes, if earlier publications or patents disclose similar formulations or methods. The patent examiners in Argentina considered such references during the approval process.
3. Is this patent enforceable outside Argentina?
Not directly. It provides territorial protection in Argentina, but similar patents in other countries depend on respective patent applications and grants.
4. How long will this patent remain valid?
Twenty years from the earliest filing date, generally expected to expire around 2040–2041, subject to maintenance fees.
5. What are the implications for generic manufacturers?
They must design around the claims or wait until patent expiry to market similar products freely.
References
- Argentine Patent Office (InPI). (2023). Patent AR036659 Details. Retrieved from [official database].
- WIPO. (2023). Patent Landscape Report. Available at [WIPO database].
- WHO. (2022). Pharmaceutical Patents and Innovation. Geneva.
- European Patent Office. (2023). Patent Search Database.
- U.S. Patent and Trademark Office. (2023). Patent Application Publications.
